|1.||Kirsch, Donald R: 3 articles (08/2015 - 01/2012)|
|2.||Morimoto, Richard I: 3 articles (08/2015 - 01/2012)|
|3.||Silverman, Richard B: 3 articles (08/2015 - 01/2012)|
|4.||Fox, Susan G: 2 articles (08/2015 - 09/2014)|
|5.||Zhao, Kevin Tianmeng: 2 articles (08/2015 - 09/2014)|
|6.||Ferrante, Robert J: 2 articles (08/2015 - 01/2012)|
|7.||Kim, Jinho: 2 articles (08/2015 - 01/2012)|
|8.||Liu, Lang: 2 articles (04/2015 - 08/2011)|
|9.||Benmohamed, Radhia: 2 articles (09/2014 - 01/2012)|
|10.||Devkar, R V: 1 article (10/2015)|
05/01/1994 - "[Pyrazolone allergy]."
01/01/1988 - "The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. "
01/01/1986 - "Many peripherally acting analgesic and anti-inflammatory drugs, including pyrazolone derivatives, can precipitate idiosyncratic hypersensitivity reactions in intrinsic asthmatics. "
04/15/1983 - "Allergy to pyrazolone-drugs were observed in 20 cases during the same period. "
01/01/1981 - "[Hypersensitivity to pyrazolone drugs (author's transl)]."
06/01/2010 - "Glucocorticoid and pyrazolone treatment of acute fever is a risk factor for critical and life-threatening human enterovirus 71 infection during an outbreak in China, 2008."
04/01/2014 - "The adjusted odds ratio (OR) of having a severe attack for being a migrant was 2.45, having a fever >39°C (OR 5.77), visiting a private clinic (OR 2.65), longer time from symptom onset to diagnosis (OR 1.49), visiting a doctor (OR 1.51), early use of intramuscular pyrazolone (OR 3.36), early use of intravenous glucocorticoids (OR 2.28), or the combination of both (OR 3.75). "
06/01/1972 - "The antipyretic effect of pyrazolone derivatives and salicylates on fever induced with leukocytic or bacterial pyrogen."
11/14/1983 - "The major antipyretic agents, acetaminophen, aspirin, and pyrazolone derivatives, are equally effective in reducing fever. "
09/01/2006 - "In order to study the possible role of prostaglandins, the animals were treated with either a urocortin together with the pyrazolone derivative noraminophenazone to inhibit the action of cyclooxygenase in initiating hyperthermia, or with noraminophenazone 30 min following urocortin administration to act on existing hyperthermia. "
08/22/2011 - "The results show that the two compounds exhibit improved photochromic performance in coloration and thermal bleaching rates, excellent photostability, high fatigue resistance, and reversible fluorescence switching properties in the solid state in comparison to reported pyrazolone thiosemicarbazones. "
04/01/2013 - "The aim of this study was to characterize the new mPGES-1 inhibitor compound II, a pyrazolone that has similar potency on rat and human recombinant mPGES-1, in experimental models of inflammation. "
03/01/2006 - "The anti-inflammatory activity of a new class of phenyl-pyrazolone derivatives, structurally related to phenidone, has been evaluated using the Croton oil ear test in mice as model of acute inflammation. "
|1.||Aspirin (Acetylsalicylic Acid)
|2.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|6.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
|10.||Histocompatibility Antigens Class II